Myeloma UK
Clinical Service Excellence Programme

Menu

Home
CPD & Learning
Library
Resources
News & Events
- News
- Event calendar
- Meeting highlights
- Close
CSEP
About Us
- Contact Us
- Close

Menu back

MNLP – Module 8 – Final assessment

Time limit: 0

Quiz-summary

0 of 20 questions completed

Questions:

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Information

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You have to pass the previous Module’s quiz in order to start this quiz:

Results

Quiz complete. Results are being recorded.

Results

0 of 20 questions answered correctly

Your time:

Time has elapsed

You have reached 0 of 0 point(s), (0)

Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)

Categories

Not categorized 0%

Congratulations on completing Final Assessment 8.

Proceed to Final Assessment 9 »

Return to the Module list »

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Answered
Review

Question 1 of 20

1. Question
1 point(s)
Is the following statement true or false:

Symptoms and complications arise solely as a result of the myeloma.
- A. True
- B. False
Correct

Incorrect
Question 2 of 20

2. Question
1 point(s)
Which of the following is the least common presenting symptom or complication of myeloma?
- A. Renal impairment
- B. Bone pain
- C. Anaemia
- D. Recurrent infection
- E. Thrombocytopenia
Correct

Incorrect
Question 3 of 20

3. Question
1 point(s)
What percentage of myeloma patients present with disease-related pain?
- A. 40%
- B. 50%
- C. 60%
- D. 70%
- E. 80%
Correct

Incorrect
Question 4 of 20

4. Question
1 point(s)
Which factor is associated with a lowering of pain tolerance?
- A. Relief of symptoms
- B. Anxiety
- C. Exercise
- D. Rest
- E. Mood elevation
Correct

Incorrect
Question 5 of 20

5. Question
4 point(s)
Match the type of pain relief given to the grade of pain
Sort elements
- Chronic moderate to severe pain
- Mild pain
- Acute severe pain
- Mild to moderate pain
- A. High-dose tramadol, fentanyl patch, morphine
- B. Paracetamol, short-term NSAID
- C. Subcutaneous opioid therapy
- D. Low-dose tramadol, co-codamol, codeine
Correct

Incorrect
Question 6 of 20

6. Question
1 point(s)
Leukopenia is a reduction in
- A. B lymphocytes
- B. T lymphocytes
- C. Neutrophils
- D. Macrophages
- E. All white blood cells
Correct

Incorrect
Question 7 of 20

7. Question
1 point(s)
Which of the following drugs is not considered to be associated with myelosuppression?
- A. Dexamethasone
- B. Melphalan
- C. Velcade
- D. Thalidomide
- E. Revlimid
Correct

Incorrect
Question 8 of 20

8. Question
1 point(s)
What haemoglobin level is graded as severe anaemia?
- A. > 120g/L
- B. 100 – 120g/L
- C. 80 – 100g/L
- D. 65 – 80g/L
- E. < 65g/L
Correct

Incorrect
Question 9 of 20

9. Question
1 point(s)
Patients presenting with symptoms of anaemia should be assessed for the following except
- A. Vital signs
- B. Blood culture samples
- C. Areas of bleeding
- D. Nutritional status
- E. Psychological assessment
Correct

Incorrect
Question 10 of 20

10. Question
1 point(s)
Routine antibiotic prophylaxis is usually recommended for which patients?
- A. All newly diagnosed myeloma patients
- B. Patients receiving Velcade
- C. Transplant patients
- D. Patients who have recently relapsed
- E. None of the above
Correct

Incorrect
Question 11 of 20

11. Question
1 point(s)
Bisphosphonate treatment is not recommended for myeloma patients if they have which complication?
- A. Renal failure
- B. Anaemia
- C. Vertebral compression fracture
- D. Peripheral neuropathy
- E. Venous thromboembolic event
Correct

Incorrect
Question 12 of 20

12. Question
1 point(s)
Which of the following is not known to cause neuropathy in myeloma patients?
- A. Velcade
- B. Spinal cord compression
- C. Hyperviscosity
- D. Cyclophosphamide
- E. Thalidomide
Correct

Incorrect
Question 13 of 20

13. Question
1 point(s)
Which class of drug can increase the risk of a thromboembolic event?
- A. Proteasome inhibitors
- B. Steroids
- C. Immunomodulatory drugs
- D. Chemotherapy agents
- E. Monoclonal antibodies
Correct

Incorrect
Question 14 of 20

14. Question
1 point(s)
Anaemia affects different systems of the body. Can you match the symptom to the correct system below?
```
Drag and drop one answer only to each category.
```
Sort elements
- Tachycardia
- Fluid retention
- Vertigo, dizziness
- Shortness of breath
- Arrhythmia
- Renal oedema
- Headache
- Hypertension
- Cardiovascular
- Urinary
- Central nervous
- Cardio-respiratory
Correct

Incorrect
Question 15 of 20

15. Question
1 point(s)
Assertion: Fatigue is reported as a symptom in approximately 90% of myeloma patients at some point during the course of their disease

BECAUSE

Reason: Fatigue in a healthy individual resolves after rest and sleep
- A. True True – reason correctly explains assertion
- B. True True – both statements are true but the reason does not explain the assertion
- C. True False
- D. False True
- E. False False
Correct

Incorrect
Question 16 of 20

16. Question
1 point(s)
Assertion: The most common location for a thromboembolic event is the lung

BECAUSE

Reason: Myeloma patients with a family history of thromboembolic events are at greater risk of developing a deep vein thrombosis
- A. True True – reason correctly explains assertion
- B. True True – both statements are true but the reason does not explain the assertion
- C. True False
- D. False True
- E. False False
Correct

Incorrect
Question 17 of 20

17. Question
1 point(s)
Erythropoietin and immunoglobulin replacement therapy are commonly used as supportive treatments for myeloma patients
- A. True
- B. False
Correct

Incorrect
Question 18 of 20

18. Question
3 point(s)
Can you match the symptoms associated with the different types of peripheral neuropathy?
Sort elements
- Motor neuropathy
- Autonomic neuropathy
- Sensory neuropathy
- Muscle weakness, cramping
- Postural hypotension, constipation
- Loss of sensation, tingling and numbness
Correct

Incorrect
Question 19 of 20

19. Question
1 point(s)
The most effective way of treating myeloma-related renal impairment is to
- A. Correct hypercalcaemia
- B. Reduce the light chain load
- C. Discontinue nephrotoxic drugs
- D. Treat existing infection
- E. Vigorously rehydrate
Correct

Incorrect
Question 20 of 20

20. Question
1 point(s)
Dose intensification is the initial recommended step in the management of treatment-related myelosuppression
- A. True
- B. False
Correct

Incorrect

Bottom menu

Charity No. SC 026116
Myeloma UK
22 Logie Mill
Beaverbank Business Park
Edinburgh
EH7 4HG

MNLP – Module 8 – Final assessment